Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,591 | -1,650 | -866 | -8,949 | -7,399 |
| Other Working Capital | -231 | -572 | -453 | 133 | 647 |
| Other Operating Activity | 50 | 22 | 15 | -740 | -787 |
| Operating Cash Flow | $-2,771 | $-2,199 | $-1,303 | $-9,556 | $-7,538 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,311 | 1,505 | 1,505 | 5,044 | 4,452 |
| Financing Cash Flow | $3,311 | $1,505 | $1,505 | $5,044 | $4,452 |
| Beginning Cash Position | 3,027 | 3,027 | 3,027 | 7,538 | 7,538 |
| End Cash Position | 3,566 | 2,332 | 3,228 | 3,027 | 4,453 |
| Net Cash Flow | $540 | $-695 | $201 | $-4,512 | $-3,086 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,771 | -2,199 | -1,303 | -9,556 | -7,538 |
| Free Cash Flow | -2,771 | -2,199 | -1,303 | -9,556 | -7,538 |